Statins, Metformin Can Cut Odds for Brain Aneurysms

2024-06-06
THURSDAY, June 6, 2024 -- Common drugs used to control cholesterol, blood sugar and high blood pressure might also lower a person’s risk of stroke, a new study finds.
The researchers evaluated the risk of brain aneurysms that cause bleeding strokes in patients.
For the study, they looked at the medical records for nearly 4,900 patients who had a bleeding stroke, and compared them against nearly 44,000 people who never had a brain aneurysm.
They identified four specific drugs that appeared to lower the risk of a brain aneurysm, after accounting for other risk factors:
“We urgently need new ways to prevent this type of stroke, which occurs at younger ages and with a higher death rate than other types of stroke,” said researcher Jos Peter Kanning, with the University Medical Center Utrecht in the Netherlands.
“Our current surgical treatments for brain aneurysms have a risk of permanent disability and death that often outweighs the potential benefits, so preventing rupture with a noninvasive drug would be very beneficial,” Kanning added in a university news release.
On the other hand, four drugs increased the risk of a bleeding stroke: the blood thinner warfarin, the antidepressant venlafaxine, the antipsychotic prochlorperazine, and the painkiller co-codamol.
The findings, which were published June 5 in the journal Neurology, only show an association between these drugs and stroke risk, the researchers noted.
“Future research is needed to investigate these associations and determine whether these drugs are effective in reducing the risk of hemorrhagic stroke,” Kanning said. “This work could also help us identify additional risk factors for subarachnoid hemorrhage, potentially leading to new therapies to manage aneurysms.”
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。